Poster

Adenovirus Vector Vaccine Platform

By Sofiya Fedosyuk, Thomas Merritt, Ada Lam, Nicolas Laroudie, Anilkumar Kangokar, Adam Ritchie, Alex Xenopoulos, Youness Cherradi, Josselyn Haas, Alexander D Douglas and Anissa Boumlic

MilliporeSigma and the University of Oxford, Jenner Institute have entered into a collaboration to advance the development of a rapid, scalable and GMP compliant process for simian adenoviruses used as a vector for vaccines against infectious diseases such as rabies and emerging threats like Zika and Ebola. This work aimed at the transition from a labor and time intensive process development to a process platform utilizing disposable technologies and novel purification techniques. This collaboration was formed to achieve defined productivity target and to develop a platform for various adenovirus serotypes used at the Institute.

Learn more about the GMP transferable process for adenovirus vector-based vaccines manufacturing that was successfully developed with Jenner Institute.

VIEW THE POSTER!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of BioProcess Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: